Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

NF-κB functions as a tumour promoter in inflammation-associated cancer

NF-κB functions as a tumour promoter in inflammation-associated cancer The causes of sporadic human cancer are seldom recognized, but it is estimated that carcinogen exposure and chronic inflammation are two important underlying conditions for tumour development, the latter accounting for approximately 20% of human cancer 1 . Whereas the causal relationship between carcinogen exposure and cancer has been intensely investigated 2 , the molecular and cellular mechanisms linking chronic inflammation to tumorigenesis remain largely unresolved 1 . We proposed that activation of the nuclear factor κB (NF-κB), a hallmark of inflammatory responses 3 that is frequently detected in tumours 4,5 , may constitute a missing link between inflammation and cancer. To test this hypothesis, we studied the Mdr2-knockout mouse strain, which spontaneously develops cholestatic hepatitis followed by hepatocellular carcinoma 6 , a prototype of inflammation-associated cancer 7 . We monitored hepatitis and cancer progression in Mdr2-knockout mice, and here we show that the inflammatory process triggers hepatocyte NF-κB through upregulation of tumour-necrosis factor-α (TNFα) in adjacent endothelial and inflammatory cells. Switching off NF-κB in mice from birth to seven months of age, using a hepatocyte-specific inducible IκB-super-repressor transgene, had no effect on the course of hepatitis, nor did it affect early phases of hepatocyte transformation. By contrast, suppressing NF-κB inhibition through anti-TNFα treatment or induction of IκB-super-repressor in later stages of tumour development resulted in apoptosis of transformed hepatocytes and failure to progress to hepatocellular carcinoma. Our studies thus indicate that NF-κB is essential for promoting inflammation-associated cancer, and is therefore a potential target for cancer prevention in chronic inflammatory diseases. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Springer Journals

NF-κB functions as a tumour promoter in inflammation-associated cancer

Download PDF
6 pages

Loading next page...
 
/lp/springer-journals/nf-b-functions-as-a-tumour-promoter-in-inflammation-associated-cancer-BY2qAIjBz8

References (29)

Publisher
Springer Journals
Copyright
Copyright © 2004 by Macmillan Magazines Ltd.
Subject
Science, Humanities and Social Sciences, multidisciplinary; Science, Humanities and Social Sciences, multidisciplinary; Science, multidisciplinary
ISSN
0028-0836
eISSN
1476-4687
DOI
10.1038/nature02924
Publisher site
See Article on Publisher Site

Abstract

The causes of sporadic human cancer are seldom recognized, but it is estimated that carcinogen exposure and chronic inflammation are two important underlying conditions for tumour development, the latter accounting for approximately 20% of human cancer 1 . Whereas the causal relationship between carcinogen exposure and cancer has been intensely investigated 2 , the molecular and cellular mechanisms linking chronic inflammation to tumorigenesis remain largely unresolved 1 . We proposed that activation of the nuclear factor κB (NF-κB), a hallmark of inflammatory responses 3 that is frequently detected in tumours 4,5 , may constitute a missing link between inflammation and cancer. To test this hypothesis, we studied the Mdr2-knockout mouse strain, which spontaneously develops cholestatic hepatitis followed by hepatocellular carcinoma 6 , a prototype of inflammation-associated cancer 7 . We monitored hepatitis and cancer progression in Mdr2-knockout mice, and here we show that the inflammatory process triggers hepatocyte NF-κB through upregulation of tumour-necrosis factor-α (TNFα) in adjacent endothelial and inflammatory cells. Switching off NF-κB in mice from birth to seven months of age, using a hepatocyte-specific inducible IκB-super-repressor transgene, had no effect on the course of hepatitis, nor did it affect early phases of hepatocyte transformation. By contrast, suppressing NF-κB inhibition through anti-TNFα treatment or induction of IκB-super-repressor in later stages of tumour development resulted in apoptosis of transformed hepatocytes and failure to progress to hepatocellular carcinoma. Our studies thus indicate that NF-κB is essential for promoting inflammation-associated cancer, and is therefore a potential target for cancer prevention in chronic inflammatory diseases.

Journal

Nature – Springer Journals

Published: Aug 25, 2004

There are no references for this article.